P/E at 61.88 vs Industry's 60.87: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Reflecting Sector Confidence

The current P/E of 61.88 for Apollo Hospitals Enterprise Ltd. sits slightly above the hospital industry average of 60.87, indicating investors are willing to pay a premium of approximately 1.7%. This premium suggests a degree of confidence in the company’s earnings growth prospects relative to its peers. However, the narrow margin between the stock’s P/E and the sector average implies valuation is broadly in line with industry expectations rather than representing an extreme outlier.

Given the hospital sector’s overall valuation, which tends to be elevated due to steady demand and defensive characteristics, Apollo Hospitals Enterprise Ltd. appears fairly priced on a relative basis. The market cap of ₹1,21,354.25 crores further cements its status as a large-cap stalwart within the sector. Apollo Hospitals Enterprise Ltd.’s valuation premium invites the question previously rated Hold, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Strong Long-Term Gains Amid Mixed Short-Term Signals

Examining the stock’s returns reveals a compelling long-term growth story. Over the past 10 years, Apollo Hospitals Enterprise Ltd. has delivered a remarkable 550.53% return, far exceeding the Sensex’s 188.16% gain in the same period. Similarly, the five-year return of 161.96% dwarfs the Sensex’s 46.58%, and the three-year return of 64.11% outperforms the benchmark’s 21.46%.

Year-to-date, the stock has gained 19.84%, contrasting sharply with the Sensex’s 9.97% decline. The one-year return of 20.42% further highlights the stock’s resilience and ability to generate alpha. However, shorter-term performance is more mixed. The three-month return of 16.22% is positive and well above the Sensex’s 3.39%, but the one-week return shows a slight decline of 0.66% versus a 1.58% gain for the Sensex. The stock’s one-day gain of 0.33% also trails the Sensex’s 0.89% loss, reflecting some recent volatility.

This divergence between short-term softness and longer-term strength raises the question is this short-term weakness a pause in momentum or a signal of deeper challenges?

Moving Average Configuration: Technicals Suggest Consolidation with Upward Bias

The technical picture for Apollo Hospitals Enterprise Ltd. reveals the stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a solid medium- to long-term uptrend. However, it remains below its 5-day moving average, suggesting some near-term consolidation or profit-taking.

This configuration often signals a stock in a recovery phase within a broader uptrend, where short-term momentum is temporarily subdued but the overall trend remains positive. The stock is currently 3.2% away from its 52-week high of ₹8,624.2, underscoring its proximity to recent peak levels. The two-day consecutive decline with a cumulative fall of 0.89% highlights this short-term hesitation — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Context: Hospital Industry Shows Mixed Results Amidst Defensive Demand

The hospital sector, to which Apollo Hospitals Enterprise Ltd. belongs, has generally exhibited defensive characteristics with steady demand. While specific sector-wide performance data is not detailed here, the industry’s P/E of 60.87 reflects elevated valuations consistent with growth expectations and stable earnings visibility.

Within this context, Apollo Hospitals Enterprise Ltd.’s valuation premium is modest, suggesting it is neither an extreme outperformer nor undervalued relative to peers. The stock’s recent underperformance relative to the sector by 0.43% on the day and a slight negative return over the past week indicate some short-term pressure, but the broader sector environment remains supportive. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously assigned a Hold rating to Apollo Hospitals Enterprise Ltd.. This rating was updated on 11 May 2026, reflecting a reassessment based on the company’s evolving fundamentals, valuation, and technicals. While the current rating is not disclosed, the data-driven approach highlights the stock’s strong long-term performance, modest valuation premium, and mixed short-term momentum.

The rating update invites investors to consider what the current rating implies for portfolio positioning given the stock’s recent price action and sector dynamics.

Conclusion: Data Reflects a Stock Balancing Valuation and Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight premium to its sector, supported by strong long-term returns and a solid technical foundation. The stock’s performance over one, three, and five years significantly outpaces the Sensex, underscoring its growth credentials.

Short-term indicators, including a recent dip below the 5-day moving average and a small decline over the past week, suggest some consolidation or profit-taking. Yet, the stock remains above key medium- and long-term moving averages, indicating the broader trend remains intact. The reassessment of the rating from Hold reflects these nuanced dynamics.

Investors may wish to explore whether the current rating aligns with their investment horizon and risk appetite, given the balance of valuation and momentum signals.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →